Date Filed | Type | Description |
12/28/2022 |
4
| LINTON JEFFREY D (EVP, General Counsel/Secretary) has filed a Form 4 on NEXTGEN HEALTHCARE, INC.
Txns:
| Paid exercise price by delivering 12,655 shares
@ $18.95, valued at
$239.8k
Paid exercise price by delivering 2,755 shares
@ $18.95, valued at
$52.2k
Exercised 25,525 rights
@ $0 |
|
11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/26/2022 |
4
| LINTON JEFFREY D (EVP, General Counsel/Secretary) has filed a Form 4 on NEXTGEN HEALTHCARE, INC.
Txns:
| Paid exercise price by delivering 1,677 shares
@ $17.02, valued at
$28.5k
Exercised 3,384 rights
@ $0 |
|
06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/28/2021 |
4
| LINTON JEFFREY D (EVP, General Counsel/Secretary) has filed a Form 4 on NEXTGEN HEALTHCARE, INC.
Txns:
| Paid exercise price by delivering 2,749 shares
@ $17.84, valued at
$49k
|
|
11/04/2021 |
4
| LINTON JEFFREY D (EVP, General Counsel/Secretary) has filed a Form 4 on NEXTGEN HEALTHCARE, INC.
Txns:
| Granted 21,819 shares
@ $0 Granted 47,450 rights
@ $0 |
|
10/28/2021 |
4
| LINTON JEFFREY D (EVP, General Counsel/Secretary) has filed a Form 4 on NEXTGEN HEALTHCARE, INC.
Txns:
| Paid exercise price by delivering 3,683 shares
@ $14.93, valued at
$55k
|
|
10/26/2021 |
4
| LINTON JEFFREY D (EVP, General Counsel/Secretary) has filed a Form 4 on NEXTGEN HEALTHCARE, INC.
Txns:
| Paid exercise price by delivering 2,479 shares
@ $14.74, valued at
$36.5k
|
|
06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/29/2020 |
4
| LINTON JEFFREY D (EVP, General Counsel/Secretary) has filed a Form 4 on NEXTGEN HEALTHCARE, INC.
Txns:
| Paid exercise price by delivering 2,548 shares
@ $18.44, valued at
$47k
|
|
10/28/2020 |
4
| LINTON JEFFREY D (EVP, General Counsel/Secretary) has filed a Form 4 on NEXTGEN HEALTHCARE, INC.
Txns:
| Granted 22,286 shares
@ $0 Granted 33,429 rights
@ $0 |
|
10/26/2020 |
4
| LINTON JEFFREY D (EVP, General Counsel/Secretary) has filed a Form 4 on NEXTGEN HEALTHCARE, INC.
Txns:
| Paid exercise price by delivering 2,478 shares
@ $15.01, valued at
$37.2k
|
|
06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/25/2018 |
4
| LINTON JEFFREY D (EVP, General Counsel/Secretary) has filed a Form 4 on NEXTGEN HEALTHCARE, INC.
Txns:
| Granted 20,000 shares
@ $0 Granted 20,400 rights
@ $0 |
|
12/05/2017 |
4
| LINTON JEFFREY D (EVP, General Counsel/Secretary) has filed a Form 4 on QUALITY SYSTEMS, INC
Txns:
| Granted 135,000 options to buy
@ $14.38, valued at
$1.9M
|
|
12/05/2017 |
3
| LINTON JEFFREY D (EVP, General Counsel/Secretary) has filed a Form 3 on QUALITY SYSTEMS, INC |
09/07/2016 |
4
| LINTON JEFFREY D (Sr VP, GC & Secretary) has filed a Form 4 on SEQUENOM INC
Txns:
| Unknown transaction of 42,853 shares
@ $0 Disposed/sold 45,771 options to buy
@ $1.59, valued at
$72.8k
Disposed/sold 123,229 options to buy
@ $1.59, valued at
$195.9k
Disposed/sold 75,000 restricted stock units
@ $0 Disposed/sold 12,000 restricted stock units
@ $0 Disposed/sold 127,000 restricted stock units
@ $0 |
|
06/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/06/2016 |
4
| LINTON JEFFREY D (Sr VP, GC & Secretary) has filed a Form 4 on SEQUENOM INC
Txns:
| Bought 10,000 shares
@ $1.1467, valued at
$11.5k
|
|
02/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/11/2005 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
02/02/2004 |
5
| LINTON JEFFREY D (President Chemicon Division) has filed a Form 5 on SEROLOGICALS CORP |
02/10/2003 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |